ERRATUM: A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post al... by Claire Horgan, Alexandros Kanellopoulos, Shankara Paneesha, Bhuvan Kishore, Richard Lovell, Emmanouil Nikolousis

Get full text

A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic... by Claire Horgan, Alexandros Kanellopoulos, Shankara Paneesha, Bhuvan Kishore, Richard Lovell, Emmanouil Nikolousis

Get full text

Fatal systemic angiomatosis with widespread sclerotic skeletal changes, diagnosed with the aid of a bone marrow biopsy: the lymphatics enter the bone marrow by Zbigniew Rudzki, Richard Lovell, Ben Miller, Vidhya Murthy, Shankara Paneesha, Guy Pratt, Neil Smith

Get full text

Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm by Anand Lokare, Emmanouil Nikolousis, Neil Phillips, Zbignieuw Rudzki, Richard Lovell, Bhuvan Kishore, Don Milligan, Shankara Paneesha

Get full text

P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MAR... by L. H. Sehn, K. Hübel, S. Luminari, A. Salar, B. E. Wahlin, A. K. Gopal, C. Bonnet, S. Paneesha, M. Trneny, H. Mashegu, C. Lihou, D. Li, C. W. Scholz

Get full text

Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia by Helen M. Parry, Nikhil Mirajkar, Natasha Cutmore, Jianmin Zuo, Heather Long, Marwan Kwok, Ceri Oldrieve, Chris Hudson, Tatjana Stankovic, Shankara Paneesha, Melanie Kelly, Jusnara Begum, Tina McSkeane, Guy Pratt, Paul Moss

Get full text

Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia by H. Parry, G. McIlroy, R. Bruton, M. Ali, C. Stephens, S. Damery, A. Otter, T. McSkeane, H. Rolfe, S. Faustini, N. Wall, P. Hillmen, G. Pratt, S. Paneesha, J. Zuo, A. Richter, P. Moss

Get full text

First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantati... by Claire Horgan, Charalampos Kartsios, Emmanouil Nikolousis, Paneesha Shankara, Bhuvan Kishore, Richard Lovell, Vidhya Murthy, Zbigniew Rudzki, Sara Dyer, Pam Holtom, Gillian Thompson, Maria Kaparou, Evgenia Xenou, Rebecca Lloyd, Indrani Venkatadasari, Alexandros Georgios Kanellopoulos

Get full text

Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial by Elizabeth H. Phillips, Catherine Burton, Amy A. Kirkwood, Sharon Barrans, Anthony Lawrie, Simon Rule, Russell Patmore, Ruth Pettengell, Kirit M. Ardeshna, Silvia Montoto, Shankara Paneesha, Laura Clifton‐Hadley, David C. Linch, Andrew K. McMillan

Get full text

Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 studyResearch in context by Marek Trněný, Abraham Avigdor, Matthew S. McKinney, Shankara Paneesha, Björn E. Wahlin, John S. Hrom, David Cunningham, Nicholas Morley, Miguel Canales, Mariana Bastos-Oreiro, David Belada, Liliana Devizzi, Fred Zheng, Douglas J. DeMarini, Wei Jiang, Ping Jiang, Ryan C. Lynch

Get full text

Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia by Thomas Roberts, Grace Uwenedi, Rachel Bruton, Graham McIlroy, Sarah Damery, Panagiota Sylla, Nicola Logan, Sam Scott, May Lau, Ahmed Elzaidi, Siobhan Plass, Soumyajit Mallick, Katie Spencer, Christine Stephens, Christopher Bentley, Guy Pratt, Jianmin Zuo, Shankara Paneesha, Brian Willett, Paul Moss, Helen Parry

Get full text

Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 studyResearch in context by Pier Luigi Zinzani, Marek Trněný, Vincent Ribrag, Vittorio Ruggero Zilioli, Jan Walewski, Jacob Haaber Christensen, Vincent Delwail, Guillermo Rodriguez, Parameswaran Venugopal, Morton Coleman, Caroline Dartigeas, Caterina Patti, Fabrizio Pane, Wojciech Jurczak, Michal Taszner, Shankara Paneesha, Fred Zheng, Douglas J. DeMarini, Wei Jiang, Aidan Gilmartin, Amitkumar Mehta

Get full text

Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real‐world intention‐to‐treat analysis by O'Reilly, MA, Wilson, W, Burns, D, Kuhnl, A, Seymour, F, Uttenthal, B, Besley, C, Alajangi, R, Creasey, T, Paneesha, S, Elliot, J, Gonzalez Arias, C, Iyengar, S, Wilson, MR, Delaney, A, Rubio, L, Lambert, J, Begg, K, Boyle, S, Cheok, KPL, Collins, GP, Roddie, C, Johnson, R, Sanderson, R

Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia by Helen Parry, Graham McIlroy, Rachel Bruton, Sarah Damery, Grace Tyson, Nicola Logan, Chris Davis, Brian Willett, Jianmin Zuo, Myah Ali, Manjit Kaur, Christine Stephens, Dawn Brant, Ashley Otter, Tina McSkeane, Hayley Rolfe, Sian Faustini, Alex Richter, Sophie Lee, Farooq Wandroo, Salim Shafeek, Guy Pratt, Shankara Paneesha, Paul Moss

Get full text

S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS IN A HIGH RATE OF MRD NEGATIVITY IN PREVIOUSLY UNTREATED CLL: THE RESULTS OF THE PLANNED INTERIM ANALYSIS OF THE PHASE II... by P. Hillmen, A. Pitchford, A. Bloor, A. Pettitt, P. Patten, F. Forconi, A. Schuh, C. Fox, N. Elmusharaf, S. Gatto, B. Kennedy, J. Gribben, N. Pemberton, O. Sheehy, G. Preston, D. Howard, A. Hockaday, D. Cairns, S. Jackson, N. Greatorex, N. Webster, S. Dalal, J. Shingles, K. Cwynarski, S. Paneesha, D. Allsup, A. Rawstron, T. Munir

Get full text

P1102: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: UPDATED OUTCOMES FROM A MULTICENTRE, REAL-WORLD UK STUDY by Rohan Shotton, Ann Tivey, Toby A. Eyre, David Lewis, Rebecca Allchin, Harriet Walter, Fiona Miall, Rui Zhao, Anna Santarsieri, Rory Mcculloch, Mark Bishton, Victoria Willimott, Nicole Fowler, Claudia Bedford, Jack Goddard, Samuel Protheroe, Mahesh Prahladan, Miriam Reeve, Shankara Paneesha, Helen Marr, Jamie Wilson, Kushani Ediriwickrema, Chloe Knott, David Wrench, Georgina Talbot, Kim Linton

Get full text

Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight by Johannes Schetelig, Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Falk Heidenreich, Jorinde D. Hoogenboom, Stephen R. Spellman, Alexander Kulagin, Thomas Schroeder, Henrik Sengeloev, Peter Dreger, Edouard Forcade, Jan Vydra, Eva Maria Wagner-Drouet, Goda Choi, Shankara Paneesha, Nuno A. A. Miranda, Alina Tanase, Liesbeth C. de Wreede, Vinzenz Lange, Alexander H. Schmidt, Alexander H. Schmidt, Jürgen Sauter, Joshua A. Fein, Yung-Tsi Bolon, Meilun He, Steven G. E. Marsh, Shahinaz M. Gadalla, Sophie Paczesny, Annalisa Ruggeri, Christian Chabannon, Katharina Fleischhauer

Get full text

P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY by A. Tivey, R. Shotton, T. A. Eyre, D. Lewis, N. Crosbie, E. Nga, R. Guerrero Camacho, W. Swe, H. Marr, C. Rees, S. Moule, T. Sutton, D. Wrench, N. Thomas, M. Wilson, J. Bailey, M. Prahladan, A. Hodson, M. Koppana, S. Smith, S. Jones, F. Miall, J. Norman, E. Davies, C. Hildyard, L. Lowry, S. Paneesha, I. Qureshi, A. Beech, C. Bedford, A. Everden, D. Tucker, J. Wright, J. Goddard, T. Nicholson, J. Wilson, A. Lord, B. Jackson, M. Flont, A. Gibb, K. Linton

Get full text